Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW) -- Ignore unavailable to you. Want to Upgrade?

To: Stock Watcher who wrote (43442)	2/21/2001 12:39:15 AM
From: Bernard Ng	Respond to of 52051

... will do Neil.. ggg EOM Bernard

To: Stock Watcher who wrote (43442)	2/21/2001 7:03:22 AM
From: BlueCheap	Read Replies (1) \| Respond to of 52051

FONAR's QUAD 12000 MRI Scanner Sites Receiving ACR Accreditation ACR Site Accreditation Now Mandated by Certain Major Insurance Carriers MELVILLE, N.Y.--(BW HealthWire)--Feb. 21, 2001--FONAR Corporation (NASDAQ-FONR), The Patient-Friendly(TM) MRI Company, announced today that several MRI scanning facilities equipped with QUAD(TM) 12000's, the Company's premiere 0.6 Tesla Open MRI, have received MRI accreditation from the American College of Radiology (ACR), the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. Certain major insurance carriers now require their MRI providers to be accredited by the ACR. Dr. Raymond V. Damadian, president and chairman of FONAR Corporation, said, ``We are pleased that the QUAD(TM) 12000 is meeting the high standards set by the ACR. It's an important achievement for us because it's a truly objective measure of the performance of our equipment. The fact that the accreditation process is being conducted by highly regarded representatives of the radiological community makes it that much more rewarding. At the same time, it confirms the effectiveness of our intensified, company-wide quality control program. Potential customers can be assured that FONAR products are quality products.'' A number of major insurance companies are requiring that provider facilities performing MRI scans on their members be accredited by the ACR MRI Accreditation Program. These include Aetna, U.S. Healthcare and Empire Blue Cross and Blue Shield in certain regions of the country. Dr. Damadian continued, ``It's a great comfort to both existing and potential FONAR customers to learn of the success of our QUAD(TM) 12000 users, especially in light of the possibility that, in the future, additional insurance companies and other third party payors will also require ACR accreditation of their providers.'' The Company reports that other QUAD(TM) 12000 users are currently seeking ACR accreditation. The ACR's MRI Accreditation Program evaluates equipment performance, quality of images, qualifications of personnel and effectiveness of quality control measures, factors believed to be of primary importance in regard to the quality of clinical images and the quality of patient care. The first of the two-part accreditation process includes the review of credentials of physicians, physicists and technologists; the second part involves the acquisition of clinical and phantom images and corresponding data for each. The Company's full product line, the FONAR Seven, also includes the Stand-Up MRI(TM), the world's only positional MRI (pMRI) scanner, enabling patients to be scanned in upright, weight-bearing positions as well as in the conventional lie-down position; the economical Echo(TM); the FONAR-360 (TM), available in its ``open sky'' configuration and, in the future, in its ``interventional 360'' configuration for MRI-guided interventions; its works-in-progress mpExtremity(TM), a Stand-Up extremity scanner; and its works-in-progress Pinnacle(TM) with superconducting MRI technology. Be sure to visit FONAR's Web site for Company product and investor information. www.fonar.com This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission. Contact: FONAR Corporation, Melville Daniel Culver, Director of Communications David Terry, VP, Secretary Tel: 631/694-2929 Fax: 631/390-9540 investor@fonar.com